glp 1 rebound weight gain While nearly 18% of U.S. adults have taken a GLP-1 drug for loss or to treat a chronic condition, about half of people will stop taking it within a year. Often Research shows most people regain

10.1159/000324992 Neuropsychobiology

This potential change in consumer profile for many American consumers should be assessed as a business risk and opportunity for businesses across different industries, including the CPG industry

For example, liraglutide has been shown to improve neural function through multiple signaling pathways, whereas semaglutide appears to exert more pronounced effects on neuroinflammation and neural tissue remodeling [11, 84, 86]

Adcock, I

Archived (PDF) from the original on 5 May 2020

GLP-1 which stands for glucagon-like peptide 1 is a gastrointestinal peptide made up of 30 amino acids